<ARTICLE>                              5
<RESTATED>
<MULTIPLIER>                           1,000
       
                                    
<PERIOD-TYPE>                          YEAR
<FISCAL-YEAR-END>                      DEC-31-1995
<PERIOD-END>                           DEC-31-1995
<CASH>                                     999,549
<SECURITIES>                                84,644
<RECEIVABLES>                            1,575,605
<ALLOWANCES>                                55,076
<INVENTORY>                                839,564
<CURRENT-ASSETS>                         4,138,561
<PP&E>                                   6,828,340
<DEPRECIATION>                           2,589,026
<TOTAL-ASSETS>                          14,412,503
<CURRENT-LIABILITIES>                    4,966,985
<BONDS>                                  2,592,894
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                   355,564
<OTHER-SE>                               5,077,059
<TOTAL-LIABILITY-AND-EQUITY>            14,412,503
<SALES>                                  6,504,386
<TOTAL-REVENUES>                         6,763,804
<CGS>                                    1,721,110
<TOTAL-COSTS>                            1,885,701
<OTHER-EXPENSES>                         2,896,297<F5>
<LOSS-PROVISION>                                 0<F4>
<INTEREST-EXPENSE>                         286,317
<INCOME-PRETAX>                          1,765,641
<INCOME-TAX>                               459,067
<INCOME-CONTINUING>                      1,306,575
<DISCONTINUED>                             984,349
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                             2,290,924
<EPS-PRIMARY>                                 2.01
<EPS-DILUTED>                                 1.99
<FN>
<F4>-The information called for is not given as the balances are not
     individually significant.
<F5>-Amounts include research and development, selling and general and
     administrative expenses.
</FN>